Response to R-warfarin anticoagulant effect. - Wikidata - awgldk - TriplyDB

Response to R-warfarin anticoagulant effect.

Response to R-warfarin anticoagulant effect.

http://www.wikidata.org/entity/Q48361252

about

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.

P2860

Q48360626-C73D34A7-2CC4-4423-A903-33A054C57314

P2860

Response to R-warfarin anticoagulant effect.

http://www.wikidata.org/entity/Q48361252

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Response to R-warfarin anticoagulant effect.

@en

Response to R-warfarin anticoagulant effect.

@nl

type

label

Response to R-warfarin anticoagulant effect.

@en

Response to R-warfarin anticoagulant effect.

@nl

prefLabel

Response to R-warfarin anticoagulant effect.

@en

Response to R-warfarin anticoagulant effect.

@nl

P1433

Q48361252-1F8F1179-D82B-4969-B57B-8E19B7F42A82

P1476

Q48361252-D4032F2B-3151-428B-A1DB-6F49CFC5D38F

P2093

Q48361252-A2062D0F-2C44-4443-9772-1C32BA1D2025

Q48361252-E6B33903-C639-4001-A693-24C18B8F3CC5

P2860

Q48361252-22EE9BF3-3D1A-407B-8802-7F852D63DC96

Q48361252-4BDC89F2-BA63-4347-8659-C208380B0FD1

Q48361252-5730198E-B6C4-4803-AF83-D608ACAAD00E

Q48361252-7275E53B-0E8C-4950-85CA-C8E5AF9BDE7A

Q48361252-7EA1A4FB-43EC-41FD-9C31-5D31EC06C3D6

Q48361252-D6848205-6F8E-4BDD-95F7-E2ADB56EF9DE

Q48361252-DD386848-F5B5-4A6A-8065-8B28607EE50F

Q48361252-E6BFD8DF-9EE0-4CA7-9728-1C377D53AB5E

P304

Q48361252-D1862DBA-5F27-47A2-B1FD-B8E82198477C

P31

Q48361252-DA333A1D-3F10-4BF5-A7BB-4579444784D5

P356

Q48361252-082CD6D8-A702-46FE-9D18-35F194DBDD95

P407

Q48361252-0E82BF33-9509-416B-A76D-9FECD6095BED

P433

Q48361252-F0C4820B-9019-419B-950D-95756A48373D

P478

Q48361252-5A5E9FC9-ACEC-4DED-B2A7-EA71E130CA0D

P50

Q48361252-BF5DE1E3-5419-4761-A14B-B7ED8F0DFBE4

P577

Q48361252-BEF90E99-376C-4D35-B606-4C041B2443B5

P698

Q48361252-DFED155A-826D-4FD8-8BBB-B64BC134B1BC

P921

Q48361252-DA3E1383-17E5-4181-9689-58E3AD4C63A3

P932

Q48361252-6A4B8BC4-A14F-4006-8ECF-07343FCC22D9

P356

P1433

British Journal of Clinical Pharmacology

P1476

Response to R-warfarin anticoagulant effect.

@en

P2093

Li-Yan Miao

http://www.w3.org/2001/XMLSchema#string

Nick Holford

http://www.w3.org/2001/XMLSchema#string

P2860

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Human prothrombin metabolism in normal man and in hypocoagulable subjects

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients.

[The multicenter study on the registration and follow-up of low anticoagulation therapy for the heart valve operation in China].

[Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement--3 000 Cases Follow-up].

P304

2305-2306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13344

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28735507

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5595937

http://www.w3.org/2001/XMLSchema#string